Patent · US Active

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

US12115216B2 · kind B2 · utility

0Cited by

4References

19Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Kevin A. Bray · Garnerville, US
Frank Delfino · Poughquag, US
Matthew C. Franklin · Great Neck, US
Elena S. Garnova · White Plains, US
Jessica R. Kirshner · New York, US
Douglas MacDonald · New York, US
William Olson · Ossining, US
Gavin Thurston · Briarcliff Manor, US

Key dates

Filing date	Dec 15, 2022
Grant date	Oct 15, 2024
Priority date	—
Expiry date	Dec 15, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.